Health Research Institute, National Institute of Advanced Industrial Science and Technology, 1-8-31 Midorigaoka, Ikeda, Osaka 563-8577, Japan.
Environ Toxicol. 2013 Feb;28(2):61-75. doi: 10.1002/tox.20695. Epub 2011 Mar 7.
Chromium(III) oxide (Cr(2)O(3)) is used for industrial applications such as catalysts and pigments. In the classical form, namely the fine particle, Cr(2)O(3) is insoluble and chemically stable. It is classified as a low-toxicity chromium compound. Recently, industrial application of nanoparticles (a new form composed of small particles with a diameter of ≤100 nm, in at least one dimension) has been increasing. Cellular effects induced by Cr(2)O(3) nanoparticles are not known. To shed light upon this, the release of soluble chromium from Cr(2)O(3) nano- and fine-particles in culture medium was compared. Fine Cr(2)O(3) particles were insoluble in the culture medium; on the contrary, Cr(2)O(3) nanoparticles released soluble hexavalent chromium into the culture medium. Cr(2)O(3) nanoparticles showed severe cytotoxicity. The effect of Cr(2)O(3) nanoparticles on cell viability was higher than that of fine particles. Cr(2)O(3) nanoparticles showed cytotoxicity equal to that of hexavalent chromium (K(2)Cr(2)O(7)). Human lung carcinoma A549 cells and human keratinocyte HaCaT cells showed an increase in intracellular reactive oxygen species (ROS) level and activation of antioxidant defense systems on exposure to Cr(2)O(3) nanoparticles. Exposure of Cr(2)O(3) nanoparticles led to caspase-3 activation, showing that the decrease in cell viability by exposure to Cr(2)O(3) nanoparticles was caused by apoptosis. Cellular responses were stronger in the Cr(2)O(3) nanoparticles-exposed cells than in fine Cr(2)O(3) - and CrCl(3) -exposed cells. Cellular uptake of Cr(2)O(3) particles were observed in nano- and fine-particles. The cellular influence of the extracellular soluble trivalent chromium was lower than that of Cr(2)O(3) nanoparticles. Cr(2)O(3) nanoparticles showed cytotoxicity by hexavalent chromium released at outside and inside of cells. The cellular influences of Cr(2)O(3) nanoparticles matched those of hexavalent chromium. In conclusion, Cr(2)O(3) nanoparticles have a high cytotoxic potential.
三氧化铬(Cr(2)O(3))用于工业应用,如催化剂和颜料。在经典形式中,即细颗粒形式,Cr(2)O(3)不溶且化学稳定。它被归类为低毒性铬化合物。最近,纳米颗粒(一种由直径≤100nm 的小颗粒组成的新形式,至少在一个维度上)的工业应用正在增加。Cr(2)O(3)纳米颗粒引起的细胞效应尚不清楚。为了阐明这一点,比较了 Cr(2)O(3)纳米和细颗粒在培养基中的可溶性铬释放。细 Cr(2)O(3)颗粒在培养基中不溶;相反,Cr(2)O(3)纳米颗粒将可溶性六价铬释放到培养基中。Cr(2)O(3)纳米颗粒表现出严重的细胞毒性。Cr(2)O(3)纳米颗粒对细胞活力的影响高于细颗粒。Cr(2)O(3)纳米颗粒的细胞毒性与六价铬(K(2)Cr(2)O(7))相当。人肺癌 A549 细胞和人角质形成细胞 HaCaT 细胞在暴露于 Cr(2)O(3)纳米颗粒后,细胞内活性氧(ROS)水平增加,抗氧化防御系统被激活。Cr(2)O(3)纳米颗粒的暴露导致 caspase-3 激活,表明暴露于 Cr(2)O(3)纳米颗粒导致细胞活力下降是由细胞凋亡引起的。Cr(2)O(3)纳米颗粒暴露细胞中的细胞反应强于细 Cr(2)O(3)和 CrCl(3)暴露细胞中的细胞反应。在纳米和细颗粒中观察到 Cr(2)O(3)颗粒的细胞摄取。细胞外可溶性三价铬的细胞影响低于 Cr(2)O(3)纳米颗粒。Cr(2)O(3)纳米颗粒通过细胞内外释放的六价铬表现出细胞毒性。Cr(2)O(3)纳米颗粒的细胞影响与六价铬的细胞影响相匹配。总之,Cr(2)O(3)纳米颗粒具有很高的细胞毒性潜力。